Atlas Trials

Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD

Clinical trial NCT05061368 · RECRUITING

Trial details

NCT number
NCT05061368
Sponsor
University of Alberta
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease
Start date
2022-03-01
Primary completion
2027-05-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.